Works matching AU Dreyling, Martin

Results: 142

Antikörpertherapie maligner Lymphome.

Published in:

Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 1, p. 14, doi. 10.1007/s00063-005-1115-0

By:

Buske, Christian;
Dreyling, Martin;
Unterhalt, Michael;
Hiddemann, Wolfgang

Publication type:

Article

Are Biosimilars the Future of Oncology and Haematology?

Published in:

Drugs, 2019, v. 79, n. 15, p. 1609, doi. 10.1007/s40265-019-01193-y

By:

Zinzani, Pier Luigi;
Dreyling, Martin;
Gradishar, William;
Andre, Marc;
Esteva, Francisco J.;
Boulos, Suliman;
González Barca, Eva;
Curigliano, Giuseppe

Publication type:

Article

The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.

Published in:

Drugs, 2016, v. 76, n. 6, p. 639, doi. 10.1007/s40265-016-0565-4

By:

Seiler, Till;
Hutter, Grit;
Dreyling, Martin

Publication type:

Article

Current Management of Mantle Cell Lymphoma.

Published in:

Drugs, 2007, v. 67, n. 12, p. 1689, doi. 10.2165/00003495-200767120-00004

By:

Weigert, Oliver;
Unterhalt, Michael;
Hiddemann, Wolfgang;
Dreyling, Martin

Publication type:

Article

Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.

Published in:

Nature Medicine, 2014, v. 20, n. 12, p. 1401, doi. 10.1038/nm.3740

By:

Baumann, Ursula;
Fernández-Sáiz, Vanesa;
Rudelius, Martina;
Lemeer, Simone;
Rad, Roland;
Knorn, Anna-Maria;
Slawska, Jolanta;
Engel, Katharina;
Jeremias, Irmela;
Li, Zhoulei;
Tomiatti, Viktoriya;
Illert, Anna-Lena;
Targosz, Bianca-Sabrina;
Braun, Martin;
Perner, Sven;
Leitges, Michael;
Klapper, Wolfram;
Dreyling, Martin;
Miething, Cornelius;
Lenz, Georg

Publication type:

Article

A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma - the STORM trial.

Published in:

2013

By:

Mathias Witzens-Harig;
Memmer, Marie Luise;
Dreyling, Martin;
Hess, Georg;
Witzens-Harig, Mathias

Publication type:

journal article

Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.

Published in:

Genes, Chromosomes & Cancer, 2006, v. 45, n. 2, p. 203, doi. 10.1002/gcc.20277

By:

Grit Hutter;
Miriam Scheubner;
Yvonne Zimmermann;
Joerg Kalla;
Tiemo Katzenberger;
Karin Hübler;
Sabine Roth;
Wolfgang Hiddemann;
German Ott;
Martin Dreyling

Publication type:

Article

Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities.

Published in:

Genes, Chromosomes & Cancer, 2000, v. 28, n. 4, p. 380, doi. 10.1002/1098-2264(200008)28:4<380::AID-GCC3>3.0.CO;2-4

By:

Ott, M. Michaela;
Rosenwald, Andreas;
Katzenberger, Tiemo;
Dreyling, Martin;
Krumdiek, Ann Katrin;
Kalla, Jörg;
Greiner, Axel;
Ott, German;
Müller-Hermelink, Hans Konrad

Publication type:

Article

A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas?

Published in:

Genes, Chromosomes & Cancer, 1999, v. 26, n. 3, p. 210, doi. 10.1002/(SICI)1098-2264(199911)26:3<210::AID-GCC4>3.0.CO;2-J

By:

Rosenwald, Andreas;
Ott, German;
Krumdiek, Ann Katrin;
Dreyling, Martin H.;
Katzenberger, Tiemo;
Kalla, Jörg;
Roth, Silke;
Ott, M. Michaela;
Müller-Hermelink, Hans Konrad

Publication type:

Article

Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.

Published in:

Genes, Chromosomes & Cancer, 1998, v. 22, n. 1, p. 72, doi. 10.1002/(SICI)1098-2264(199805)22:1<72::AID-GCC10>3.0.CO;2-K

By:

Dreyling, Martin H.;
Roulston, Diane;
Bohlander, Stefan K.;
Vardiman, James;
Olopade, Olufunmilayo I.

Publication type:

Article

Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.

Published in:

Hematological Oncology, 2023, v. 41, n. 5, p. 858, doi. 10.1002/hon.3194

By:

Moosburner, Marie;
Alibegovic, Lamija;
Hasselmann, Korbinian;
Gaiderov, Anton;
Hildebrand, Johannes;
Philippou‐Massier, Julia;
Blum, Helmut;
Fischer, Luca;
Dreyling, Martin;
Silkenstedt, Elisabeth

Publication type:

Article

Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches.

Published in:

Hematological Oncology, 2023, v. 41, p. 36, doi. 10.1002/hon.3149

By:

Silkenstedt, Elisabeth;
Dreyling, Martin

Publication type:

Article

Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approaches.

Published in:

2021

By:

Silkenstedt, Elisabeth;
Dreyling, Martin

Publication type:

journal article

Tumor board simulation improves interdisciplinary decision-making in medical students.

Published in:

Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 8, p. 1, doi. 10.1007/s00432-024-05908-x

By:

Fink, Kevin;
Forster, Marie;
Oettle, Matthias;
Büttner, Marcel;
Eze, Chukwuka;
Käsmann, Lukas;
Tufman, Amanda;
Kauffmann-Guerrero, Diego;
Bolt, Toki A.;
Kovacs, Julia;
Neumann, Jens;
Mücke, Johannes;
Heuser, Sonja;
Corradini, Stefanie;
Walter, Franziska;
Niyazi, Maximilian;
Belka, Claus;
Dreyling, Martin;
Fischer, Martin R.;
Fleischmann, Daniel F.

Publication type:

Article

Principles of oncology taught in a one-week course.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17071, doi. 10.1007/s00432-023-05377-8

By:

Oettle, Matthias;
Büttner, Marcel;
Forster, Marie;
Gajdi, Laura;
Mücke, Johannes;
Nieto, Alexander;
Heuser, Sonja;
Huber, Johanna;
Walter, Franziska;
Corradini, Stefanie;
Niyazi, Maximilian;
Belka, Claus;
Dreyling, Martin;
Fischer, Martin R.;
Fleischmann, Daniel F.

Publication type:

Article

Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.

Published in:

Histopathology, 2011, v. 58, n. 4, p. 586, doi. 10.1111/j.1365-2559.2011.03779.x

By:

Mi Kyung Jin;
Hoster, Eva;
Dreyling, Martin;
Unterhalt, Michael;
Hiddemann, Wolfgang;
Klapper, Wolfram

Publication type:

Article

The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stage.

Published in:

2009

By:

Willenbrock, Klaus;
Renn, Christoph;
Rottenkolber, Marietta;
Klapper, Wolfram;
Dreyling, Martin;
Engelhard, Marianne;
Küppers, Ralf;
Hansmann, Martin-Leo;
Jungnickel, Berit

Publication type:

Letter

Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells.

Published in:

International Journal of Hyperthermia, 2009, v. 25, n. 4, p. 262, doi. 10.1080/02656730902835664

By:

Milani, Valeria;
Lorenz, Monika;
Weinkauf, Marc;
Rieken, Malte;
Pastore, Alessandro;
Dreyling, Martin;
Issels, Rolf

Publication type:

Article

A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms.

Published in:

PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0006986

By:

Martin-Subero, Jose I.;
Ammerpohl, Ole;
Bibikova, Marina;
Wickham-Garcia, Eliza;
Agirre, Xabier;
Alvarez, Sara;
Brüggemann, Monika;
Bug, Stefanie;
Calasanz, Maria J.;
Deckert, Martina;
Dreyling, Martin;
Du, Ming Q.;
Dürig, Jan;
Dyer, Martin J. S.;
Jian-Bing Fan;
Gesk, Stefan;
Hansmann, Martin-Leo;
Harder, Lana;
Hartmann, Sylvia;
Klapper, Wolfram

Publication type:

Article

The Diagnosis and Treatment of Primary CNS Lymphoma: An Interdisciplinary Challenge.

Published in:

Deutsches Ärzteblatt International, 2018, v. 115, n. 25, p. 419, doi. 10.3238/arztebl.2018.0419

By:

von Baumgarten, Louisa;
Illerhaus, Gerald;
Korfel, Agnieszka;
Schlegel, Uwe;
Deckert, Martina;
Dreyling, Martin

Publication type:

Article

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.

Published in:

Cancer (0008543X), 2012, v. 118, n. 24, p. 6079, doi. 10.1002/cncr.27638

By:

Griffiths, Robert I.;
Gleeson, Michelle L.;
Mikhael, Joseph;
Dreyling, Martin H.;
Danese, Mark D.

Publication type:

Article

Aktuelle klinische Aspekte des follikulären Lymphoms.

Published in:

Therapeutische Umschau, 2010, v. 67, n. 10, p. 511, doi. 10.1024/0040-5930/a000087

By:

Dreyling, Martin

Publication type:

Article

Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network.

Published in:

British Journal of Haematology, 2025, v. 206, n. 1, p. 159, doi. 10.1111/bjh.19854

By:

Jiang, Linmiao;
Dreyling, Martin;
Hermine, Olivier;
Mansmann, Ulrich;
Walewski, Jan;
Ribrag, Vincent;
Thieblemont, Catherine;
Pott, Christiane;
Bachy, Emmanuel;
Feugier, Pierre;
Hübel, Kai;
Schumacher, Martin;
Hoster, Eva

Publication type:

Article

Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study.

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 749, doi. 10.1111/bjh.18519

By:

Hess, Georg;
Dreyling, Martin;
Oberic, Lucie;
Gine, Eva;
Zinzani, Pier Luigi;
Linton, Kim;
Vilmar, Adam;
Jerkeman, Mats;
Chen, Jenny M. H.;
Ohler, Anke;
Stilgenbauer, Stephan;
Thieblemont, Catherine;
Lambert, Jonathan;
Zilioli, Vittorio Ruggero;
Sancho, Juan‐Manuel;
Jiménez‐Ubieto, Ana;
Fischer, Luca;
Eyre, Toby A.;
Keeping, Sam;
Park, Julie E.

Publication type:

Article

A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.

Published in:

British Journal of Haematology, 2022, v. 198, n. 3, p. 482, doi. 10.1111/bjh.18161

By:

Hess, Georg;
Hüttmann, Andreas;
Witzens‐Harig, Mathias;
Dreyling, Martin H.;
Keller, Ulrich;
Marks, Reinhard;
Ernst, Thomas;
Pott, Christiane;
Viardot, Andreas;
Frontzek, Fabian;
Trautmann, Marcel;
Ruckes, Christian;
Deuster, Oliver;
Rosenwald, Andreas;
Theobald, Matthias;
Lenz, Georg

Publication type:

Article

Mantle cell lymphoma – advances in molecular biology, prognostication and treatment approaches.

Published in:

British Journal of Haematology, 2021, v. 195, n. 2, p. 162, doi. 10.1111/bjh.17419

By:

Silkenstedt, Elisabeth;
Linton, Kim;
Dreyling, Martin

Publication type:

Article

Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6).

Published in:

Annals of Hematology, 2025, v. 104, n. 4, p. 2317, doi. 10.1007/s00277-025-06355-5

By:

Fuhrmann, Stephan;
Nickelsen, Maike;
Hasenkamp, Justin;
Hüttmann, Andreas;
Dreyling, Martin;
Kiehl, Michael;
Salwender, Hans;
Placzek, Marius;
Hilgers, Reinhard;
Schmitz, Norbert;
Glass, Bertram

Publication type:

Article

Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.

Published in:

Annals of Hematology, 2024, v. 103, n. 7, p. 2373, doi. 10.1007/s00277-024-05689-w

By:

Scheubeck, Gabriel;
Hoffmann, Martin;
Jurinovic, Vindi;
Fischer, Luca;
Unterhalt, Michael;
Schmidt, Christian;
Böck, Hans-Peter;
Dührsen, Ulrich;
Kaesberger, Joachim;
Kremers, Stephan;
Lindemann, Hans-Walter;
Mantovani, Luisa;
Hiddemann, Wolfgang;
Hoster, Eva;
Dreyling, Martin

Publication type:

Article

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.

Published in:

Annals of Hematology, 2023, v. 102, n. 10, p. 2791, doi. 10.1007/s00277-023-05385-1

By:

Fischer, Luca;
Jiang, Linmiao;
Bittenbring, Joerg Thomas;
Huebel, Kai;
Schmidt, Christian;
Duell, Johannes;
Metzner, Bernd;
Krauter, Juergen;
Glass, Bertram;
Huettmann, Andreas;
Schaefer-Eckart, Kerstin;
Silkenstedt, Elisabeth;
Klapper, Wolfram;
Hiddemann, Wolfgang;
Unterhalt, Michael;
Dreyling, Martin;
Hoster, Eva

Publication type:

Article

Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphoma.

Published in:

2018

By:

Schoeppe, Franziska;
Sommer, Wieland H.;
Nörenberg, Dominik;
Verbeek, Mareike;
Bogner, Christian;
Westphalen, C. Benedikt;
Dreyling, Martin;
Rummeny, Ernst J.;
Fingerle, Alexander A.

Publication type:

journal article

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

Published in:

2017

By:

Spurgeon, Stephen E.;
Till, Brian G.;
Martin, Peter;
Goy, Andre H.;
Dreyling, Martin P.;
Gopal, Ajay K.;
LeBlanc, Michael;
Leonard, John P.;
Friedberg, Jonathan W.;
Baizer, Lawrence;
Little, Richard F.;
Kahl, Brad S.;
Smith, Mitchell R.

Publication type:

journal article

Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials.

Published in:

JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 23, p. 1799, doi. 10.1093/jnci/djr418

By:

Vidal, Liat;
Gafter-Gvili, Anat;
Salles, Gilles;
Dreyling, Martin H.;
Ghielmini, Michele;
Hsu Schmitz, Shu-Fang;
Pettengell, Ruth;
Witzens-Harig, Mathias;
Shpilberg, Ofer

Publication type:

Article

Aktuelle und künftige Indikationen mit Bendamustin: chronische lymphatische Leukämie, indolente Lymphome, Mantelzell-Lymphome und diffuse großzellige B-Zell-Lymphome.

Published in:

Oncology Research & Treatment, 2013, v. 36, p. 11, doi. 10.1159/000346106

By:

Hallek, Michael;
Knauf, Wolfgang;
Dreyling, Martin;
Trümper, Lorenz

Publication type:

Article

Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 474, doi. 10.1016/j.clml.2021.12.018

By:

Moertl, Bernhard;
Dreyling, Martin;
Schmidt, Christian;
Hoster, Eva;
Schoel, Wolfgang;
Bergwelt-Baildon, Michael v.;
Berger, Karin

Publication type:

Article

Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e886, doi. 10.1016/j.clml.2021.06.021

By:

Matasar, Matthew J.;
Dreyling, Martin;
Leppä, Sirpa;
Santoro, Armando;
Pedersen, Michael;
Buvaylo, Viktoriya;
Fletcher, Monique;
Childs, Barrett H.;
Zinzani, Pier Luigi

Publication type:

Article

IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S403, doi. 10.1016/S2152-2650(21)01911-X

By:

Schuster, Stephen J.;
Dickinson, Michael;
Dreyling, Martin;
Martinez-Lopez, Joaquin;
Kolstad, Arne;
Butler, Jason;
Ghosh, Monalisa;
Popplewell, Leslie;
Chavez, Julio C.;
Bachy, Emmanuel;
Koji Kato;
Harigae, Hideo;
Kersten, Marie José;
Andreadis, Charalambos;
Riedell, Peter;
Zia, Aiesha;
Morisse, Mony Chenda;
Fowler, Nathan Hale;
Thieblemont, Catherine

Publication type:

Article

Poster: IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01539-1

By:

Schuster, Stephen J.;
Dickinson, Michael;
Dreyling, Martin;
Martinez-Lopez, Joaquin;
Kolstad, Arne;
Butler, Jason;
Ghosh, Monalisa;
Popplewell, Leslie;
Chavez, Julio C.;
Bachy, Emmanuel;
Kato, Koji;
Harigae, Hideo;
Kersten, Marie José;
Andreadis, Charalambos;
Riedell, Peter;
Zia, Aiesha;
Morisse, Mony Chenda;
Fowler, Nathan Hale;
Thieblemont, Catherine

Publication type:

Article

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.

Published in:

2019

By:

Cheson, Bruce D.;
O'Brien, Susan;
Ewer, Michael S.;
Goncalves, Marcus D.;
Farooki, Azeez;
Lenz, Georg;
Yu, Anthony;
Fisher, Richard I.;
Zinzani, Pierre L.;
Dreyling, Martin

Publication type:

journal article

Targeting mTOR/PI3K in Primary CNS Lymphoma (PCNSL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S107, doi. 10.1016/j.clml.2016.07.155

By:

Korfel, Agnieszka;
Schorb, Elisabeth;
Schlegel, Uwe;
Dimitrijević, Saša Dimitrijević;
D'Allonzo, Saana;
Dreyling, Martin;
Herrlinger, Ullrich;
Kiewe, Philipp

Publication type:

Article

Treatment of indolent lymphoma in Germany -- results of a representative population-based survey.

Published in:

2011

By:

Schmidt, Christian;
Fetscher, Sebastian;
Görg, Christian;
Kornek, Peter;
Nusch, Arnd;
Kegel, Thomas;
Kellermann, Lenka;
Hiddemann, Wolfgang;
Fingerle-Rowson, Guenter;
Dreyling, Martin

Publication type:

Journal Article

Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 204, doi. 10.1016/j.clml.2011.03.001

By:

Schmidt, Christian;
Fetscher, Sebastian;
Görg, Christian;
Kornek, Peter;
Nusch, Arnd;
Kegel, Thomas;
Kellermann, Lenka;
Hiddemann, Wolfgang;
Fingerle-Rowson, Guenter;
Dreyling, Martin

Publication type:

Article

Management of Mantle Cell Lymphoma: Key Challenges and Next Steps.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 5, p. 336, doi. 10.3816/CLML.2010.n.066

By:

Williams, Michael E.;
Dreyling, Martin;
Winter, Jane;
Muneer, Sabeeha;
Leonard, John P.

Publication type:

Article

Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 1, p. 21, doi. 10.3816/CLML.2010.n.002

By:

Cheson, Bruce D.;
Wendtner, Clemens-Martin;
Pieper, Angelika;
Dreyling, Martin;
Friedberg, Jonathan;
Hoelzer, Dieter;
Moreau, Philippe;
Gribben, John;
Knop, Stefan;
Montillo, Marco;
Rummel, Mathias

Publication type:

Article

Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.

Published in:

2019

By:

König, Laila;
Dreyling, Martin;
Dürig, Jan;
Engelhard, Marianne;
Hohloch, Karin;
Viardot, Andreas;
Witzens-Harig, Mathias;
Kieser, Meinhard;
Klapper, Wolfram;
Pott, Christiane;
Herfarth, Klaus

Publication type:

journal article

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomasThe authors dedicate this paper to Reza Parwaresch, who served as a reference pathologist for the German Low‐Grade Lymphoma Study Group (GLSG) over many years and who died unexpectedly in November 2005.: Results of a prospective randomized trial of the German Low‐Grade Lymphoma Study Group

Published in:

Cancer (0008543X), 2006, v. 107, n. 5, p. 1014

By:

Christina Nickenig;
Martin Dreyling;
Eva Hoster;
Michael Pfreundschuh;
Lorenz Trumper;
Marcel Reiser;
Hannes Wandt;
Eva Lengfelder;
Michael Unterhalt;
Wolfgang Hiddemann

Publication type:

Article

Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphoma.

Published in:

2006

By:

Weigert, Oliver;
Illidge, Tim;
Hiddemann, Wolfgang;
Dreyling, Martin

Publication type:

journal article

The role of fludarabine in the treatment of follicular and mantle cell lymphoma.

Published in:

Cancer (0008543X), 2004, v. 101, n. 5, p. 883

By:

Georg Lenz;
Wolfgang Hiddemann;
Martin Dreyling

Publication type:

Article

Biomarkers and Prognosis in Malignant Lymphomas.

Published in:

Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 160

By:

Hagenbeek, Anton;
Gascoyne, Randy D.;
Dreyling, Martin;
Kluin, Philip;
Engert, Andreas;
Salles, Gilles

Publication type:

Article

Mantelzelllymphom: Die Kombination verschiedener Therapien führt zum Erfolg.

Published in:

Kompass Onkologie, 2022, v. 9, n. 3, p. 105, doi. 10.1159/000526780

By:

Dreyling, Martin

Publication type:

Article

Schwere Candida-glabrata-Pankolitis und letale Aspergillus-fumigatus-Lungeninfektion vor dem Hintergrund einer Knochenmarkaplasie nach CD19-spezifischer CAR T-Zell-Therapie – ein Fallbericht.

Published in:

Kompass Onkologie, 2021, v. 8, n. 3, p. 159, doi. 10.1159/000518824

By:

Rejeski, Kai;
Kunz, Wolfgang G.;
Rudelius, Martina;
Bücklein, Veit;
Blumenberg, Viktoria;
Schmidt, Christian;
Karschnia, Philipp;
Schöberl, Florian;
Dimitriadis, Konstantin;
von Baumgarten, Louisa;
Stemmler, H. Joachim;
Weigert, Oliver;
Dreyling, Martin;
von Bergwelt-Baildon, Michael;
Subklewe, Marion

Publication type:

Article